BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 290 filers reported holding BIONTECH SE in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | – | 600 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 600 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | -99.8% | 600 | -94.0% | 0.00% | -100.0% |
| Q4 2022 | $561 | -99.9% | 10,000 | -25.3% | 0.05% | +42.4% |
| Q3 2022 | $493,000 | -28.1% | 13,388 | +0.2% | 0.03% | -31.2% |
| Q2 2022 | $686,000 | -92.2% | 13,363 | -87.8% | 0.05% | -89.6% |
| Q1 2022 | $8,789,000 | +59.7% | 109,296 | +40.9% | 0.46% | +101.3% |
| Q4 2021 | $5,505,000 | +393.7% | 77,567 | +506.0% | 0.23% | +360.0% |
| Q3 2021 | $1,115,000 | +25.8% | 12,800 | +1.5% | 0.05% | +19.0% |
| Q2 2021 | $886,000 | -3.2% | 12,606 | -27.2% | 0.04% | -6.7% |
| Q1 2021 | $915,000 | +28.2% | 17,310 | -42.9% | 0.04% | +32.4% |
| Q4 2020 | $714,000 | +187.9% | 30,303 | -7.9% | 0.03% | +112.5% |
| Q3 2020 | $248,000 | -56.0% | 32,900 | -33.0% | 0.02% | -56.8% |
| Q2 2020 | $563,000 | – | 49,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
| Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
| Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
| Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
| Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
| Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
| Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
| Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
| Robbins Farley | 13,220 | $2,255,000 | 1.70% |
| APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |